mRNA-based vaccines have been one of the key elements in the fight against the coronavirus. The technology was originally developed for cancer therapy and can be used to treat many diseases. Together with partners from science and industry, Fraunhofer IPK is now researching how mRNA therapeutics and other medication can be better produced and more effectively applied.
more info